Power3 Medical Products, Inc. (OTC.BB:PWRM) a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. The company's products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease.

The company uses technologies, know-how and proprietary techniques to focus on protein-based biomarkers, which are simply proteins that are significant in the diagnosis, monitoring or treatment of disease.

For on-target treatment with new medicines the need is to identify and assess the disease-related proteins and the healthy-related proteins. Only by specifying the precise differences between disease-related and healthy-related proteins can the development of a new diagnostic test to detect the disease, and new drugs to treat the disease effectively be done.

Our research platform dates back to 1975 when Chief Scientific Officer, Dr. Ira Goldknopf, made a startling and unprecedented discovery that would change the science of proteins; the ubiquitin conjugation of proteins, Protein Ubiquitination.

******************************************

American Video Teleconferencing Corp. (PINK: AVOT) is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. The company believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. Presently the company is in the final stage of negotiations with Kondor Gold Pyt. in Australia.

The company will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.

The late leader of China, Deng Xiaoping, once said that rare earth minerals would be to China what oil was to the Middle East.

Now, policymakers and corporate leaders in the United States, Japan, Europe and other advanced economies are watching with mounting concern as China exerts market dominance by restricting exports and driving prices higher and there is little they can do.

******************************************

GlaxoSmithKline plc (NYSE:GSK) announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA). When asked if the dutasteride risk/benefit profile is favorable for reduction in the risk of prostate cancer in this target population, the ODAC voted 14 against, 2 in favor, and 2 abstentions.

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

******************************************

Assurant Inc. (NYSE:AIZ) a premier provider of specialty insurance and insurance-related products and services, announced that Robert B. Pollock, president and chief executive officer, provided an update on the company and answer questions from participants during the Goldman Sachs U.S. Financial Services Conference 2010 in New York on Tuesday, Dec. 7, 2010. Access to the archived replay of the presentation is available through the Investor Relations section of Assurant’s website.

Assurant is a premier provider of specialized insurance products and related services in North America and select worldwide markets. Assurant, a Fortune 500 company and a member of the S&P 500, is traded on the New York Stock Exchange under the symbol AIZ.

******************************************

Oshkosh Corporation (NYSE:OSK) announced that it will provide the U.S. Armed Forces with the first MRAP All-Terrain Vehicle (M-ATV) tactical ambulances, giving military medics new capabilities for reaching injured military personnel in otherwise inaccessible battlefield environments. Oshkosh received an order for 250 of the armored, highly mobile ambulances from the U.S. Army TACOM Life Cycle Management Command (LCMC).

Oshkosh Corporation designs, manufactures, and markets a range of access equipment, specialty vehicles, and vehicle bodies worldwide.

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Crown Equity Holdings Inc. (CRWE.OB) anticipates to receive 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (AVOT.PK) from the company for 12 months IR Services.